Press Release

Myomo, Inc. Introduces Center of Excellence Program

Nationwide Roster of Top O&P Practices Supports MyoPro® Powered Orthosis Nationwide Roster of Top O&P Practices Supports MyoPro® Powered Orthosis Cambridge, MA., July 12, 2017 – Myomo®, Inc. (NSYE MKT: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced the launch of its Center of Excellence (CoE) program, which recognizes top…

Read More

Myomo, Inc. Announces Publication of Significant Clinical Research

Peer-reviewed Results Indicate Significant Reduction in Upper Extremity Impairment with MyoPro®, with Changes Exceeding Clinically Important Thresholds CAMBRIDGE, Mass., June 27, 2017 – Myomo, Inc. (NYSE MKT: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced publication of an investigator-led clinical study in the Archives of Physical Medicine and Rehabilitation. The…

Read More

Myomo, Inc. Launches MyoPro® 2

Powered Arm Orthosis Features Interchangeable, Extended-life Rechargeable Batteries Myomo, Inc. (NSYE MKT: MYO) today announced the launch of its next-generation MyoPro® myoelectric arm orthosis (powered brace), the only lightweight wearable device that can restore function in the paralyzed or weakened arms and hands of individuals who have suffered a stroke, spinal cord or nerve injury,…

Read More

Myomo, Inc. Completes Historic Initial Public Offering

First company to go public on the NYSE MKT under JOBS Act Regulation A+ Cambridge, MA., June 9, 2017 – Myomo, Inc. (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced the completion of its initial public offering (IPO) under SEC Regulation A+, raising $5.0 Million through the sale of 665,498 shares…

Read More

Myomo Launches IPO Via Jobs Act Regulation A+ with Sights Set on NYSE MKT Listing

Everyday Investors Can Now Buy Stock in Pioneering Wearable Medical Robotics Company Cambridge, Mass. (March 15, 2017) ​– Myomo, Inc., ​a commercial stage medical robotics Company, ​today announced a Regulation A+ initial public offering that allows any investor the opportunity to invest in the Company’s vision for expanded mobility for those suffering from neurological disorders and…

Read More

Three Companies Receive 2017 Seed Funds to Develop Medical Devices for Children

The Philadelphia Pediatric Medical Device Consortium, based at CHOP, will fund Powered Orthotic Brace, Rapid Blood Delivery and Ear Reshaper. The Philadelphia Pediatric Medical Device Consortium (PPDC) has announced seed grants to three companies developing medical devices for children. Myomo is proud to be one of the top three picks. Read more.

Read More

Ottobock and Myomo Enter into Exclusive Global Distribution Agreement

Companies form sales partnership to offer myoelectric orthotic technology in select markets starting January 1, 2017 AUSTIN, Texas and CAMBRIDGE, Mass. (December 19, 2016) — Ottobock, a world market leader in technical orthopedics, and Myomo, Inc., a leading manufacturer of myoelectric orthotics, “Ottobock is committed to providing orthotic solutions to drive successful patient outcomes and meet…

Read More

Myomo, Inc. Launches Breakthrough Powered Grasp MyoPro Motion-G Orthosis

Cambridge, MA – October 27, 2015 — Myomo, Inc., a medical device company specializing in myoelectric orthotics for people with neuromuscular disorders, is launching the MyoPro Motion-G, a breakthrough in functional orthotics that provides elbow flexion/extension and grasping function, enabling paralyzed individuals to perform essential daily functions. The MyoPro Motion-G is the first powered orthosis to…

Read More